CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Update

CBD Life Sciences Inc. (OTCMKTS:CBDL) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,019,814 shares, an increase of 919.8% from the June 30th total of 100,000 shares. Based on an average daily trading volume, of 37,832,732 shares, the short-interest ratio is presently 0.0 days.

CBD Life Sciences Price Performance

Shares of CBD Life Sciences stock opened at $0.00 on Friday. CBD Life Sciences has a 52 week low of $0.00 and a 52 week high of $0.00.

About CBD Life Sciences

CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.

The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.